Neurogene NGNE
NASDAQ NGNE
$25.12 -0.96 (-3.68%)
As of: Oct 22, 2026 · 11:18 AM EDT

Neurogene (NGNE) EBIT Margin (2015 - 2024)

Updated

Neurogene (NGNE) posted EBIT Margin of -8930.27% for FY2024.

Analysis

Neurogene (NGNE) EBIT Margin (2015 - 2024) Analysis & Trends

  • Annual EBIT Margin shows a five-year change of -8923.17 percentage points (FY2019 to FY2024).
  • The FY2024 figure stands as the highest annual EBIT Margin since FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Eli Lilly 1,175.94 Bn 1,144.53 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 638.47 Bn 556.99 Bn 17.26 Bn 28.21%
3 AbbVie 504.39 Bn 477.51 Bn 12.70 Bn 37.86%
4 Merck 377.60 Bn 331.98 Bn 12.21 Bn -3.52%
5 Novartis Ag 304.31 Bn 268.30 Bn 11.24 Bn 32.97%
6 Astrazeneca 267.64 Bn 241.32 Bn 12.86 Bn 20.57%
7 Amgen 242.06 Bn 197.45 Bn 7.24 Bn 34.95%
8 Gilead Sciences 193.83 Bn 168.03 Bn 6.22 Bn -133.21%
9 Pfizer 172.62 Bn 119.27 Bn 10.94 Bn 28.37%
10 Neurogene 566.51 Mn -436.49 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 -2,176.65%
Mar 31, 2023 -1,379.37%
Dec 31, 2022 -1,430.27%
Sep 30, 2022 -2,434.53%
Jun 30, 2022 -8,180.93%
Mar 31, 2022 -118,192.31%
Dec 31, 2021 -303,480.00%
Sep 30, 2021 -257,533.33%
Sep 30, 2019 -5.95%
Jun 30, 2018 10.76%
Sep 30, 2016 -5,736.62%
Jun 30, 2016 -8,516.41%
Mar 31, 2016 -5,546.28%
Sep 30, 2015 -55,900.00%
Jun 30, 2015 -39,541.67%
Mar 31, 2015 -42,706.67%
API Access

Neurogene EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=NGNE&period=max&api_key=YOUR_API_KEY